Abstract:Objectives: The objectives of the study were to investigate the responses of different retinal ganglion cell (RGC) populations to diverse injuries [transient ischemia induced by acute ocular hypertension (AOH), excitotoxicity induced by intravitreal injection of 100 mM N‐methyl D‐aspartate (NMDA) or intra‐orbital optic nerve transection (IONT)] and protection with selective agonists of the tropomyosin related kinase B (TrkB) receptor, brain‐derived neurotrophic factor (BDNF) or 7,8‐Dihydroxyflavone (DHF) or with a voltage‐dependent calcium channel blocker (ITH12657). Methods: Adult Sprague–Dawley rats were used. In the first group, the left eye received a single intravitreal injection of 5 μL vehicle or 5 μg BDNF and was connected to a saline reservoir elevated above the eye to induce an acute ocular hypertension (AOH) and transient ischemia for 75 min. These rats were analysed at different survival intervals from 3 to 45 days. A second group were treated daily subcutaneously with vehicle or ITH5263 (10 mg/kg), or intraperitoneally with vehicle or DHF (5 mg/kg), starting 12 h prior to an intraocular injection of 100 mM N‐methyl‐D‐aspartate (NMDA) to induce retinal excitotoxicity. These rats were analysed at different survival intervals from 3 to 21 days. A third group received a left intra‐orbital optic nerve transection (IONT) to induce axotomy of the RGC population and were treated daily with an intraperitoneal injection of vehicle (0.9% NaCl containing 1% DMSO) or DHF (5 mg/kg diluted in vehicle). These rats were analysed at survival intervals from 3 to 60 days. The retinas were prepared as wholemounts and immunolabelled for Brn3a, melanopsin (m), Osteopontin (OPN) and the T‐box transcription factor T‐brain‐2 (Tbr2) to identify the following retinal ganglion cell populations: Brn3a + , melanopsin + , α‐like (OPN + ), α‐ON sustained RGCs (OPN + Tbr2 + ), α‐ON transient RGCs (OPN + Brn3a − Tbr2 − ) and α‐OFF like (OPN + Brn3a + ). The labelled RGCs were quantified automatically (Brn3a) or dotted manually and quantified with a graphic software, and distribution of the different populations were represented on topographical maps. Results: Our studies document that: (i) AOH induces progressive loss of Brn3a + RGCs and a significant but not progressive loss of m + RGCs. Treatment with BDNF afforded significant long‐lasting protection for both RGC populations. (ii) Intravitreal injection of NMDA resulted at 7 days in the abrupt significant loss of Brn3a + RGCs, αRGC and αONs‐RGCs without further progression, whereas αOFF‐RGCs died massively. Both m + RGCs and αONtRGCs appear fully resistant to NMDA‐induced excitotoxicity. Both ITH12657 or DHF protect Brn3a + RGC, αRGCs and αONs‐RGCs, but not αOFF‐RGCs. (iii) IONT and vehicle treatment result in a characteristic rapid loss of Brn3a, melanopsin RGCs, αRGCs, αONs‐RGCs and αOFF‐RGCs. DHFs protect Brn3a + RGC, m + RGCs, αRGCs and αONs‐RGCs, but not αOFF‐RGCs. Conclusions: Thus, three different RGC populations (Brn3a + , m + and α‐like) respond distinctly to different injuries and neuroprotective agents, further adding to the idea that each type of RGC has a unique response to injury and protection. Deciphering the molecular mechanisms of each RGC type will help understand neuronal responses to injury and its possible prevention.

Roles of PI3K and JAK pathways in viability of retinal ganglion cells after acute elevation of intraocular pressure in rats with different autoimmune backgrounds

Differential roles of phosphatidylinositol 3-kinase/akt pathway in retinal ganglion cell survival in rats with or without acute ocular hypertension.

JAK/STAT pathway mediates retinal ganglion cell survival after acute ocular hypertension but not under normal conditions

Different responses of macrophages in retinal ganglion cell survival after acute ocular hypertension in rats with different autoimmune backgrounds

Signaling mechanisms of growth hormone-releasing hormone receptor in LPS-induced acute ocular inflammation.

PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury

The Effect of A2AReceptor Antagonist on Microglial Activation in Experimental Glaucoma

Activation of Autophagy and Paraptosis in Retinal Ganglion Cells after Retinal Ischemia and Reperfusion Injury in Rats

Influence of Macrophages and Lymphocytes on the Survival and Axon Regeneration of Injured Retinal Ganglion Cells in Rats from Different Autoimmune Backgrounds

Regulation of cell death and survival pathways in secondary degeneration of the optic nerve - a long-term study

Casein kinase-II inhibition promotes retinal ganglion cell survival and axonal regeneration.

Protective Effect of A Jnk Inhibitor Against Retinal Ganglion Cell Loss Induced by Acute Moderate Ocular Hypertension

Pathological Changes and Expression of JAK-STAT Signaling Pathway Hallmark Proteins in Rat Retinas at Different Time Points After Retinal Ischemia Reperfusion Injury

Enhanced Survival of Melanopsin-expressing Retinal Ganglion Cells after Injury is Associated with the PI3 K/Akt Pathway

Idiosyncratic responses of RGCs to injury and protection

Age of Rats Affects the Degree of Retinal Neuroinflammatory Response Induced by High Acute Intraocular Pressure

Therapeutic Retrobulbar Inhibition of STAT3 Protects Ischemic Retina Ganglion Cells

[The Effect of Copolymer-1 on the Apoptosis and the IL-6R Expression of the Retinal Ganglion Cells in Chronic Elevated Intraocular Pressure Rat Model].

The Inflammasome-Dependent Dysfunction and Death of Retinal Ganglion Cells after Repetitive Intraocular Pressure Spikes

Retinal neurodegeneration in intraocular pressure fluctuation rat model

Retinal Neurodegeneration in an Intraocular Pressure Fluctuation Rat Model